DNLZ expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.461600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.904200E-01
Normal-vs-Stage2
5.304000E-01
Normal-vs-Stage3
8.395200E-01
Normal-vs-Stage4
2.639600E-01
Stage1-vs-Stage2
7.622200E-01
Stage1-vs-Stage3
6.519400E-01
Stage1-vs-Stage4
9.293600E-02
Stage2-vs-Stage3
5.774600E-01
Stage2-vs-Stage4
2.926400E-01
Stage3-vs-Stage4
3.201400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.228400E-01
Normal-vs-AfricanAmerican
9.223400E-01
Normal-vs-Asian
9.535800E-01
Caucasian-vs-AfricanAmerican
5.988800E-01
Caucasian-vs-Asian
4.638400E-01
AfricanAmerican-vs-Asian
8.510200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.105400E-01
Normal-vs-Female
5.855000E-01
Male-vs-Female
5.585400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.717200E-01
Normal-vs-Age(41-60Yrs)
8.607600E-01
Normal-vs-Age(61-80Yrs)
5.599800E-01
Normal-vs-Age(81-100Yrs)
5.616400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.320400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.705000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.115800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.774560E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.760800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.734600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.549400E-01
Normal-vs-Daily Drinker
8.307200E-01
Normal-vs-Weekly Drinker
9.497600E-01
Normal-vs-Occasional Drinker
7.631000E-01
Normal-vs-Social Drinker
9.885000E-01
Non Drinker-vs-Daily Drinker
1.930350E-01
Non Drinker-vs-Weekly Drinker
1.650380E-01
Non Drinker-vs-Occasional Drinker
5.033600E-01
Non Drinker-vs-Social Drinker
1.631020E-01
Daily Drinker-vs-Weekly Drinker
6.777600E-01
Daily Drinker-vs-Occasional Drinker
7.137000E-01
Daily Drinker-vs-Social Drinker
7.295600E-01
Weekly Drinker-vs-Occasional Drinker
5.320400E-01
Weekly Drinker-vs-Social Drinker
8.856000E-01
Occasional Drinker-vs-Social Drinker
5.750600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.915600E-01
Normal-vs-Grade 2
8.764600E-01
Normal-vs-Grade 3
8.367400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.777000E-01
Grade 1-vs-Grade 3
5.899800E-01
Grade 1-vs-Grade 4
9.915600E-01
Grade 2-vs-Grade 3
1.472190E-01
Grade 2-vs-Grade 4
8.764600E-01
Grade 3-vs-Grade 4
8.367400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.812600E-01
Normal-vs-NonDiabetic
7.115800E-01
Diabetic-vs-NonDiabetic
9.023600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.374600E-01
Normal-vs-NoPancreatitis
7.366000E-01
Pancreatitis-vs-NoPancreatitis
6.272800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.796400E-01
Normal-vs-N1
5.132400E-01
N0-vs-N1
3.712400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.652800E-01
Normal-vs-TP53-NonMutant
5.958800E-01
TP53-Mutant-vs-TP53-NonMutant
4.072400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
